Skip to content
Clemens
Contact

Meet ClemensYour New Private Equity AI Associate

He already read the deck, flagged the risk, and sent the intro.Before you asked.

Mail
Search mail

Nordvale - three things before you dial in

Inbox
Clemens
Clemens <clemens@fund3.com>
to you
8:14 AM

Hey Boss,

Quick brief before the 11am.

Their Q3 deck came in this morning. Revenue's up but the top customer is now 44% of ARR - moved since June. I'd probe that early.

Found an intro chain through someone from the Halden deal. Two steps. Want me to draft the note?

IC memo draft is ready when you need it.

C

Buy-side · The most advanced Buy-side search

From your fund's mandate to a memo the IC can defend.

Connected sources → one working model
PitchBook
Outlook
Chronograph
Slack
Datasite
Affinity
DealCloud
Teams
Intralinks
Fireflies
Capital IQ
LinkedIn
Clemens
Clemens
One working model of your mandate
Ranked targets · scored and sorted
1
Nordvale Analytics window open
Healthcare SaaS · €80–120M EV
94%
2
Centrix Medical
MedTech · €150–200M EV
87%
3
Halden Diagnostics
Diagnostics · €60–90M EV
82%
Decision-maker → shortest path in
Peter Lindqvist · CFO
Nordvale Analytics
  • Prior exit at 4× as CFO, HealthCo
  • LinkedIn: two unprompted mentions of “strategic review” in the last 60 days
  • Trust network: 3 mutual connections
Intro chain
Markus Renn
Markus Renn
you
Jan Eriksson
Jan Eriksson
prior board colleague
Peter Lindqvist
Peter Lindqvist
target
2 steps · high credibility
You push back · he refines · he drafts
Markus Renn
Markus Renn 9:14 AM

what's the actual growth story here? feels like it could be a one-customer business

Clemens
Clemens 9:15 AM

Top customer is 44% of ARR — the other 8 span three sectors. Concentration is real, but not a one-customer business.

Markus Renn
Markus Renn 9:18 AM

ok I'm convinced. draft the IC memo

Clemens
Clemens 9:21 AM

IC memo ready.

Nordvale Analytics — IC Memo.pdf
PDF · Fund III · every claim source-linked

Sell-side · The deepest Sell-side prep

From day one of the hold to a higher final multiple.

Institutional memory · compiled over the hold
Nordvale Analytics CEO · 6y CFO · 2y Board · 4 Cust #1 · 44% Cust #2 · 18% Cust #3 · 9% Rival A · new SKU Rival B · price cut MDR class IIa Board deck Q1 Board deck Q2 Board deck Q3 LP letter Press ×7
847 signals · 124 sources · 3 yrs
Continuous monitoring · sourced signals
HIGH
Customer concentration
Q3 audit · HubSpot top-3 timeline
HIGH
MDR class IIa renewal Q4
Regulatory filing NL
MED
Founder succession
Fireflies · Q2 board
LOW
Reagent pricing
Industry benchmark
live · past 24h
Exit readiness — every angle covered
94
Exit readiness
94 / 100
Ready to run
Regulatory
MDR renewal filed
Cleared
Customer concentration
Disclosed · 3-yr trend
Cleared
Founder succession
Board-approved plan
Cleared
Financials
Restated · source-linked
Cleared
The same portco — without Clemens vs with Clemens
T
Without Clemens With Clemens

Powered by Research.tech

Clemens is not a chatbot reading a document.

Every finding is produced by a multi-agent research engine that reasons across hundreds of signals, maintains a live knowledge graph of each company, and backs every conclusion with a cited primary source.

Multi-agent architecture

Parallel agents handle sourcing, cross-verification, and synthesis. No single point of failure. No hallucinated conclusions.

Live knowledge graph

Every company, person, and relationship mapped and updated continuously. The more Clemens works, the more he knows.

Every claim source-cited

Nothing surfaces without a traceable source. You see what was found, where, and when. Full audit trail on every output.

Cross-verification by default

Internal documents checked against external reality. If the CIM says one thing and the public record says another, Clemens flags the gap.

Hey boss, Clemens already did the work

You see more

Deal sourcing

You prepare deeper

DD, memos

You hold smarter

Portco monitoring

You exit higher

Sell-side advantage